- Chile has endured a sharp uptick in Covid infections in recent weeks, even with its world-renowned vaccine rollout and strict lockdowns in place.
- A study published by the University of Chile earlier this month reported that CoronaVac was 56.5% effective two weeks after the second doses were administered in the country. Crucially, however, they also reported that one dose was only 3% effective.
- “I cannot stress this enough — for most countries, vaccines are not going to stop this wave of the pandemic,” Carissa Etienne, director of PAHO, said during a weekly press briefing on Wednesday.
Chile’s vaccination campaign against the coronavirus has been one of the world’s quickest and most extensive, but a recent surge in infections has sparked concern beyond its borders.
Almost 40% of the South American country’s total population have now received at least one dose of a Covid-19 vaccine, according to statistics compiled by Our World in Data, reflecting one of the highest vaccination rates in the world.
Only Israel and the U.K., respectively, have inoculated a larger share of their population with at least one dose.
Nonetheless, Chile has endured a sharp uptick in coronavirus infections in recent weeks, even with its world-renowned vaccine rollout and strict lockdowns in place for much of its 19 million inhabitants.
The Pan American Health Organization’s regional director has since emphasized that for most countries in the region, vaccines won’t be enough to prevent rising infection rates.
The number of daily cases in Chile rose to a record high on April 9, climbing above 9,000 for the first time since the pandemic began and significantly higher than the peak of almost 7,000 recorded last summer.